Analyzing the Winners and Losers in the Growth of …


Success of Delivery Device Developers in Solving Formulation Limitations a Key Factor according to Greystone Research Associates (Amherst, NH) – As patients live longer and the prevalence and incidence of chronic ailments increase across the general population, drug developers and their delivery device partners are adapting to address what will become a significant market opportunity. Chronic conditions require drug…
Read More
Autoinjectors Gaining Acceptance as Suppliers Adju…
Improved Designs and Enhanced Ease-of-Use Features Key Factors in Patient Acceptance according to Greystone Research Associates (Amherst, NH) – The aging global population is having a major impact on the growing emphasis on drug self-administration.An ageing global population will decrease the economic growth of any country. This is because of a decrease in the labour participation in that particular country. Because of the ageing population it will lead to more consumption from the government funds. This is because the healthcare demands will rise. Read next on the impact of the ageing population on healthcare. This trend is creating an increased demand for medical devices that are patient-friendly and cost-effective. Autoinjectors, a relatively new class of injection devices, have…
Read More
Therapeutic Antibody Drugs Being Designed for Self…
Pipeline Candidates Being Formulated for Subcutaneous Delivery Proliferating according to Greystone Research Associates (Amherst, NH) – The administration of therapeutic antibodies is becoming an increasingly important healthcare treatment option for a growing number diseases and indications having broad implications for patient health and well-being. But to fully exploit the value of this class of therapeutics in both…
Read More
Boehringer is winning on social media
Biopharma has encountered more critics than cheerleaders as it has cautiously edged into social media, but Boehringer Ingelheim has recently won a high-profile supporter–Twitter ($TWTR). In a case study, the social network praised Boehringer’s use of its platform. PMLiVE spotted the case study on Twitter’s business-focused website. On the site, Twitter describes the social media tactics that have helped…
Read More
Tracking 20 Years of Compound-to-Target Output fro…
The statistics of drug development output and declining yield of approved medicines has been the subject of many recent reviews. However, assessing research productivity that feeds development is more difficult. Here we utilise an extensive database of structure-activity relationships extracted from papers and patents. We have used this database to analyse published compounds cumulatively linked to nearly 4000 protein target…
Read More
Pneumonia and Diarrhea continue to be the leading …
New Progress Report finds that India continues to have low coverage levels for prevention and treatment interventions for these easily preventable diseases New Delhi, 12 November, 2013 – The Pneumonia and Diarrhea Progress Report 2013 published by the International Vaccine Access Center (IVAC) at Johns Hopkins Bloomberg School of Public Health today highlights that India continues to have the largest pneumonia and diarrheal…

Share:

You might also like …